Cargando…

Seven myths of randomisation in clinical trials

Detalles Bibliográficos
Autor principal:	Senn, Stephen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Invited Speaker Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3287816/ http://dx.doi.org/10.1186/1745-6215-12-S1-A95

Ejemplares similares

Myths, need, contribution to the diagnosis
por: Bozzao, Alessandro
Publicado: (2015)

Randomised controlled trials of complex interventions
por: Norrie, John
Publicado: (2011)

Removing unnecessary obstacles to randomised trials
por: Collins, Rory
Publicado: (2013)

Strategies for handling missing data in randomised trials
por: White, Ian R
Publicado: (2011)

Using biomarkers prospectively in adaptive clinical trials
por: Berry, Donald A
Publicado: (2011)

Science in a crisis: conducting clinical trials in an emergency
por: Horby, P
Publicado: (2015)

The UK Medical Research Council and clinical trials, 1934-1960
por: Chalmers, Iain
Publicado: (2013)

When to decide to enroll a TTR-FAP patient in a Clinical Trial?
por: Buades, Juan
Publicado: (2015)

Streamlining regulation of clinical trials – update on the Academy of Medical Sciences review and government’s response
por: Ford, Gary A
Publicado: (2011)

Using economic modelling to contribute to the prioritisation and design and clinical trials: ready for prime time
por: Sculpher, Mark
Publicado: (2011)

Next-generation clinical sequencing in a children’s hospital
por: Kingsmore, Stephen
Publicado: (2011)

Equivalence and non inferiority trials
por: D’Agostino, Ralph B
Publicado: (2011)

EDI200 therapeutic trial
por: Huttner, Kenneth
Publicado: (2012)

The madness of HIV prevention trials
por: McCormack, S
Publicado: (2015)

Discussion session: biomarker trials
Publicado: (2015)

S5. Proffered paper: Maintenance therapy of metastatic colorectal carcinoma with the TLR-9 agonist MGN1703: clinical and immunological predictive pretreatment factors of activity in the IMPACT trial
por: Schmoll, H, et al.
Publicado: (2014)

Investigator led trials: challenges and opportunities
por: Sandercock, Peter
Publicado: (2011)

Identifying appropriate phase II trial designs
por: Brown, Sarah R
Publicado: (2011)

Trials in rare diseases: the need to think differently
por: Billingham, Lucinda, et al.
Publicado: (2011)

Survival analysis: coping with non proportional hazards in randomized trials
por: Royston, Patrick, et al.
Publicado: (2011)

Clinical use of pharmacogenomics
por: Telenti, Amalio
Publicado: (2012)

Science, society and biosafety of a field trial with transgenic biofuel poplars
por: Van Acker, Rebecca, et al.
Publicado: (2011)

Clinical impact of food processing
por: Baumert, Joseph
Publicado: (2011)

Immunological and clinical effects of probiotics
por: Eigenmann, Philippe
Publicado: (2011)

The clinical picture and outcome in adults
por: Elewaut, Dirk
Publicado: (2014)

Spondyloarthritis - the clinical picture in children
por: Vargas, Ruben Burgos
Publicado: (2014)

Recruitment to trials - why is it hard and how might we make it less so?
por: Treweek, Shaun
Publicado: (2011)

INSP-04. Confirmatory adaptive designs for survival trials with several time-to-event endpoints
por: Schmidt, Rene
Publicado: (2022)

Clinical utility of thresholds versus CRD
por: Bindslev-Jensen, Carsten
Publicado: (2011)

Statistical issues in the analysis of non-pharmacological therapy trials with clustering by care-provider or therapy group
por: Roberts, Chris
Publicado: (2011)

The heel fat pad: mechanical properties and clinical applications
por: Wearing, Scott C, et al.
Publicado: (2011)

Peach allergy: different clinical profiles across Europe
por: Fernandez-Rivas, Montserrat
Publicado: (2011)

Clinical thresholds in food allergy and their application in risk assessment management
por: Houben, Geert
Publicado: (2011)

Are clinical genomes already becoming semi-routine for patient care?
por: Boguski, Mark
Publicado: (2011)

PReS13-SPK-1321: Expanding clinical spectrum of autoinflammatory diseases
por: Aksentijevich, I
Publicado: (2013)

S4 prescribing for podiatrists
por: Marty, Stephen
Publicado: (2011)

Adverse effects
por: Evans, Stephen JW
Publicado: (2011)

Treg in CNS autoimmune disease
por: Anderton, Stephen M
Publicado: (2012)

Control of livestock ectoparasites with entomopathogenic fungi: a review
por: Abolins, Stephen, et al.
Publicado: (2010)

S49. Clinical activity and development of biomarkers for an engineered anti PDL1 antibody MPDL3280A
por: Cha, E
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_bpnoo3fjfb7brgiekgft4idltc